Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Retained Deficit	Total
Beginning Balance at Dec. 31, 2017	$ 762	$ 16,404,673	$ (14,740,922)	$ 1,664,513
Beginning Balance, Shares at Dec. 31, 2017	76,145,418
Issuance of common stock from the exercise of warrants	$ 6	109,994		110,000
Issuance of common stock from the exercise of warrants, shares	569,797
Issuance of common stock from the exercise of stock options	$ 1	(1)
Issuance of common stock from the exercise of stock options, shares	125,307
Stock based compensation due to common stock purchase options		122,497		122,497
Net loss			(649,147)	(649,147)
Ending Balance at Mar. 31, 2018	$ 769	16,637,163	(15,390,069)	1,247,863
Ending Balance, Shares at Mar. 31, 2018	76,840,522
Beginning Balance at Dec. 31, 2018	$ 872	32,187,580	(16,861,763)	15,326,689
Beginning Balance, Shares at Dec. 31, 2018	87,175,522
Stock based compensation due to common stock purchase options		832		832
Net loss			(519,266)	(519,266)
Ending Balance at Mar. 31, 2019	$ 872	$ 32,188,412	$ (17,381,029)	$ 14,808,255
Ending Balance, Shares at Mar. 31, 2019	87,175,522